Celldex Therapeutics
CLDX
#4936
Rank
โ‚ฌ1.49 B
Marketcap
22,51ย โ‚ฌ
Share price
-2.71%
Change (1 day)
-5.21%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2025 (TTM): -โ‚ฌ0.23 Billion

According to Celldex Therapeutics's latest financial reports the company's current earnings are โ‚ฌ2.6 Million. In 2024 the company made an earning of -โ‚ฌ0.17 Billion a decrease over its 2023 earnings that were of -โ‚ฌ0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.23 Billion38.22%
2024 -โ‚ฌ0.17 Billion37.34%
2023 -โ‚ฌ0.13 Billion32.63%
2022 -โ‚ฌ90.85 Million54.88%
2021 -โ‚ฌ58.66 Million39.49%
2020 -โ‚ฌ42.06 Million-9.08%
2019 -โ‚ฌ46.26 Million-28.64%
2018 -โ‚ฌ64.82 Million-30.11%
2017 -โ‚ฌ92.75 Million-17.75%
2016 -โ‚ฌ0.12 Billion4.5%
2015 -โ‚ฌ0.11 Billion4.09%
2014 -โ‚ฌ0.11 Billion51.57%
2013 -โ‚ฌ68.4 Million40.1%
2012 -โ‚ฌ48.82 Million
2010 -โ‚ฌ1.06 Million-96.59%
2009 -โ‚ฌ31.05 Million
2006 -โ‚ฌ18.98 Million
2004 -โ‚ฌ11.53 Million15.75%
2003 -โ‚ฌ9.96 Million-18.69%
2002 -โ‚ฌ12.25 Million-41.22%
2001 -โ‚ฌ20.83 Million59%
2000 -โ‚ฌ13.1 Million27.65%
1999 -โ‚ฌ10.27 Million53.12%
1998 -โ‚ฌ6.71 Million2.6%
1997 -โ‚ฌ6.54 Million-33.62%
1996 -โ‚ฌ9.85 Million-1.69%
1995 -โ‚ฌ10.01 Million22.92%
1994 -โ‚ฌ8.15 Million-0%
1993 -โ‚ฌ8.15 Million
1991 -โ‚ฌ5.01 Million90.32%
1990 -โ‚ฌ2.63 Million10.71%
1989 -โ‚ฌ2.38 Million833.33%
1988 -โ‚ฌ0.26 Million-400%
1987 โ‚ฌ0.08 M-125%
1986 -โ‚ฌ0.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Seagen
SGEN
-โ‚ฌ0.68 Billion 208.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ17.52 M-108.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.14 B-164.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ6.99 B-3,317.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.05 B-4,725.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ7.90 B-3,738.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-โ‚ฌ2.38 Million-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA